Clin2
NCT06863571Possibly a fitRecruiting

Early medication combo to reduce swelling after stroke

Ischemic Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a combination of medicines given early after a large ischemic stroke to reduce brain swelling. It may help people who have had a stroke in the middle cerebral artery within the last 3 days and have a large area of brain damage.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
68 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had a stroke caused by a blocked artery in the middle of the brain within the last 3 days.
  • The stroke area is large (80–300 mL) or has a low ASPECTS score (1–5) on a brain scan.
  • You are not scheduled for a surgery to remove part of your skull to reduce brain pressure.
  • You do not have severe low blood pressure (less than 90 systolic) or signs of brain herniation.
  • You are not allergic to certain blood pressure or heart rate medications (like terazosin, urapidil, esmolol, or propranolol).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07668323Recruiting· Phase 3
Clot-dissolving medication for stroke caused by medium vessel blockage

This study tests whether giving clot-dissolving medication directly into the blocked brain artery (intra-arterial thrombolysis) improves recovery from acute stroke caused by a medium-sized vessel blockage. It aims to see if this treatment helps patients regain function better than standard care.

Nanjing, Jiangsu
NCT06551727Enrolling by invitation
Stroke progression treatment: blood pressure and antiplatelet therapy

This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.

Shanghai, Shanghai Municipality
NCT06863558Not yet recruiting· Phase 3
Early medication combination to reduce swelling after a brain bleed

This study tests whether giving a combination of blood-pressure-lowering medicines early after a brain bleed can reduce swelling and improve recovery. It aims to start treatment within 3 days of the bleed to see if it helps limit brain damage.

NCT03481205Recruiting
Air-transport treatment to protect brain tissue after stroke

This trial studies a protective “conditioning” treatment given during air ambulance transport for people with a suspected large-vessel ischemic stroke. The goal is to reduce further brain injury and preserve more brain tissue while you’re being transported for stroke care.

Iowa City, Iowa
NCT06663631Recruiting· Phase 1
Hibernation-like therapy for stroke recovery after clot removal

This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.

Linyi, Shandong
NCT06437600Recruiting
Immediate balloon angioplasty for severe stroke with brain artery narrowing

This trial tests whether doing an angioplasty (a procedure to open a narrowed artery with a small balloon) as soon as possible after a severe stroke caused by a blockage in a brain artery can improve recovery. It is for people who arrive within 24 hours of their stroke and have a specific type of narrowing inside the skull.

Guangzhou, Guangdong

Hear when a new Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.